{
    "id": 29558,
    "fullName": "MAP3K8 - GNG2",
    "impact": "fusion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "MAP3K8-GNG2 results from a fusion between MAP3K8 and GNG2, resulting in increased MEK1/2 phosphorylation in cell culture (PMID: 30833747). MAP3K8-GNG2 has been identified in spitzoid melanoma (PMID: 30833747).",
            "references": [
                {
                    "id": 14474,
                    "pubMedId": 30833747,
                    "title": "Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30833747"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1326,
        "geneSymbol": "MAP3K8",
        "terms": [
            "MAP3K8",
            "AURA2",
            "c-COT",
            "COT",
            "EST",
            "ESTF",
            "MEKK8",
            "Tpl-2",
            "TPL2"
        ]
    },
    "variant": "MAP3K8 - GNG2",
    "createDate": "03/14/2019",
    "updateDate": "03/14/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 54331,
                "geneSymbol": "GNG2",
                "terms": [
                    "GNG2"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 16376,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, treatment with Mekinist (trametinib) resulted in some decrease in lesion size and number in a patient with spitzoid melanoma harboring MAP3K8-GNG2, however, the patient experienced cardiotoxicity and efficacy did not continue, and Mekinist (trametinib) therapy was discontinued (PMID: 30833747).",
            "molecularProfile": {
                "id": 31617,
                "profileName": "MAP3K8 - GNG2"
            },
            "therapy": {
                "id": 2,
                "therapyName": "Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 3162,
                "name": "malignant spindle cell melanoma",
                "source": "DOID"
            },
            "responseType": "unknown",
            "references": [
                {
                    "id": 14474,
                    "pubMedId": 30833747,
                    "title": "Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30833747"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31617,
            "profileName": "MAP3K8 - GNG2",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}